190 related articles for article (PubMed ID: 22732549)
1. Regulation of atherogenesis by chemokine receptor CCR6.
Wan W; Murphy PM
Trends Cardiovasc Med; 2011 Jul; 21(5):140-4. PubMed ID: 22732549
[TBL] [Abstract][Full Text] [Related]
2. Genetic deletion of chemokine receptor Ccr6 decreases atherogenesis in ApoE-deficient mice.
Wan W; Lim JK; Lionakis MS; Rivollier A; McDermott DH; Kelsall BL; Farber JM; Murphy PM
Circ Res; 2011 Aug; 109(4):374-81. PubMed ID: 21680896
[TBL] [Abstract][Full Text] [Related]
3. CCR6 selectively promotes monocyte mediated inflammation and atherogenesis in mice.
Manthey HD; Cochain C; Barnsteiner S; Karshovska E; Pelisek J; Koch M; Chaudhari SM; Busch M; Eckstein HH; Weber C; Koenen RR; Zernecke A
Thromb Haemost; 2013 Dec; 110(6):1267-77. PubMed ID: 24114205
[TBL] [Abstract][Full Text] [Related]
4. CCL18 aggravates atherosclerosis by inducing CCR6-dependent T-cell influx and polarization.
Singh A; Kraaijeveld AO; Curaj A; Wichapong K; Hammerich L; de Jager SCA; Bot I; Atamas SP; van Berkel TJC; Jukema JW; Comerford I; McColl SR; Mees B; Heemskerk JWM; Nicolaes GAF; Hackeng T; Liehn EA; Tacke F; Biessen EAL
Front Immunol; 2024; 15():1327051. PubMed ID: 38807599
[TBL] [Abstract][Full Text] [Related]
5. Chemokine Receptor-6 Promotes B-1 Cell Trafficking to Perivascular Adipose Tissue, Local IgM Production and Atheroprotection.
Srikakulapu P; Upadhye A; Drago F; Perry HM; Bontha SV; McSkimming C; Marshall MA; Taylor AM; McNamara CA
Front Immunol; 2021; 12():636013. PubMed ID: 33679793
[TBL] [Abstract][Full Text] [Related]
6. The relationship between CCR6 and its binding partners: does the CCR6-CCL20 axis have to be extended?
Lee AY; Phan TK; Hulett MD; Körner H
Cytokine; 2015 Mar; 72(1):97-101. PubMed ID: 25585877
[TBL] [Abstract][Full Text] [Related]
7. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
Frick VO; Rubie C; Keilholz U; Ghadjar P
World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629
[TBL] [Abstract][Full Text] [Related]
8. Cysteine-cysteinyl chemokine receptor 6 mediates invariant natural killer T cell airway recruitment and innate stage resistance during mycobacterial infection.
Stolberg VR; Chiu BC; Martin BE; Shah SA; Sandor M; Chensue SW
J Innate Immun; 2011; 3(1):99-108. PubMed ID: 21042003
[TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis.
Hammerich L; Bangen JM; Govaere O; Zimmermann HW; Gassler N; Huss S; Liedtke C; Prinz I; Lira SA; Luedde T; Roskams T; Trautwein C; Heymann F; Tacke F
Hepatology; 2014 Feb; 59(2):630-42. PubMed ID: 23959575
[TBL] [Abstract][Full Text] [Related]
10. CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice.
Doucet M; Jayaraman S; Swenson E; Tusing B; Weber KL; Kominsky SL
J Bone Miner Res; 2016 Jul; 31(7):1381-90. PubMed ID: 26890063
[TBL] [Abstract][Full Text] [Related]
11. Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells.
Röhrl J; Yang D; Oppenheim JJ; Hehlgans T
J Biol Chem; 2010 Mar; 285(10):7028-34. PubMed ID: 20068036
[TBL] [Abstract][Full Text] [Related]
12. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.
Nandi B; Pai C; Huang Q; Prabhala RH; Munshi NC; Gold JS
PLoS One; 2014; 9(5):e97566. PubMed ID: 24866282
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived CCL20 affects B16 melanoma growth in mice.
Martin-Garcia D; Silva-Vilches C; Will R; Enk AH; Lonsdorf AS
J Dermatol Sci; 2020 Jan; 97(1):57-65. PubMed ID: 31883833
[TBL] [Abstract][Full Text] [Related]
14. CCL20/CCR6 chemokine signaling is not essential for pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Sachi N; Kamiyama N; Saechue B; Ozaka S; Dewayani A; Ariki S; Chalalai T; Soga Y; Fukuda C; Kagoshima Y; Ekronarongchai S; Kobayashi T
Biochem Biophys Res Commun; 2023 Jan; 641():123-131. PubMed ID: 36527746
[TBL] [Abstract][Full Text] [Related]
15. CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC.
Kallal LE; Schaller MA; Lindell DM; Lira SA; Lukacs NW
Eur J Immunol; 2010 Apr; 40(4):1042-52. PubMed ID: 20101616
[TBL] [Abstract][Full Text] [Related]
16. CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis.
Williams IR
Ann N Y Acad Sci; 2006 Aug; 1072():52-61. PubMed ID: 17057190
[TBL] [Abstract][Full Text] [Related]
17. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer.
Ghadjar P; Rubie C; Aebersold DM; Keilholz U
Int J Cancer; 2009 Aug; 125(4):741-5. PubMed ID: 19480006
[TBL] [Abstract][Full Text] [Related]
18. CCR6 is transiently upregulated on B cells after activation and modulates the germinal center reaction in the mouse.
Wiede F; Fromm PD; Comerford I; Kara E; Bannan J; Schuh W; Ranasinghe C; Tarlinton D; Winkler T; McColl SR; Körner H
Immunol Cell Biol; 2013 May; 91(5):335-9. PubMed ID: 23588497
[TBL] [Abstract][Full Text] [Related]
19. CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis.
Turner JE; Paust HJ; Steinmetz OM; Peters A; Riedel JH; Erhardt A; Wegscheid C; Velden J; Fehr S; Mittrücker HW; Tiegs G; Stahl RA; Panzer U
J Am Soc Nephrol; 2010 Jun; 21(6):974-85. PubMed ID: 20299360
[TBL] [Abstract][Full Text] [Related]
20. CCL20 blockade increases the severity of nephrotoxic folic acid-induced acute kidney injury.
González-Guerrero C; Morgado-Pascual JL; Cannata-Ortiz P; Ramos-Barron MA; Gómez-Alamillo C; Arias M; Mezzano S; Egido J; Ruiz-Ortega M; Ortiz A; Ramos AM
J Pathol; 2018 Oct; 246(2):191-204. PubMed ID: 29984403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
